SPONSOR
Barbara Ann Karmanos Cancer Institute
Total Trials
5
Recruiting
5
Phases
Phase 2
Conditions studied: Renal AL AmyloidosisDuctal Carcinoma in SituStage I Breast CancerStage II Breast CancerStage III Breast CancerHepatocellular Carcinoma RecurrentMetastatic Pancreatic AdenocarcinomaBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIA
Barbara Ann Karmanos Cancer Institute is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Renal AL Amyloidosis, Ductal Carcinoma in Situ, Stage I Breast Cancer, Stage II Breast Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Barbara Ann Karmanos Cancer Institute
How many clinical trials has Barbara Ann Karmanos Cancer Institute sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Barbara Ann Karmanos Cancer Institute, of which 5 are actively recruiting participants. These trials cover conditions including Renal AL Amyloidosis, Ductal Carcinoma in Situ, Stage I Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Barbara Ann Karmanos Cancer Institute research focus on?
Barbara Ann Karmanos Cancer Institute clinical trials span Renal AL Amyloidosis, Ductal Carcinoma in Situ, Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Barbara Ann Karmanos Cancer Institute clinical trial?
To participate in a Barbara Ann Karmanos Cancer Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Barbara Ann Karmanos Cancer Institute trials with current recruitment status updated daily.
Clinical Trials by Barbara Ann Karmanos Cancer Institute
NCT06420167 Phase 2
Recruiting
DapagliFLOzin in Renal AL Amyloidosis (FLORAL)
Renal AL Amyloidosis
NCT07095114
Recruiting
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
Ductal Carcinoma in Situ
NCT07118202
Recruiting
TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma Recurrent
NCT06576115 Phase 2
Recruiting
Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
Metastatic Pancreatic Adenocarcinoma
NCT07218432
Recruiting
A Study of the TheraBionic P1 Device in Breast Cancer
Breast Cancer Stage I
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology